Antibiotic therapy for Shigella dysentery
- 7 October 2009
- reference entry
- research article
- Published by Wiley
- No. 4,p. CD006784
- https://doi.org/10.1002/14651858.cd006784.pub2
Abstract
Shigella dysentery is a relatively common illness and occasionally causes death, worldwide. Mild symptoms are self-limiting but in more severe cases, antibiotics are recommended for cure and preventing relapse. The antibiotics recommended are diverse, have regional differences in sensitivity, and have side effects. To evaluate the efficacy and safety of antibiotics for treating Shigella dysentery. In June 2009 we identified all relevant trials from the following databases: Cochrane Infectious Diseases Group Specialized Register; Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2008, issue 4), MEDLINE, EMBASE, LILACS and the metaRegister of Controlled Trials (mRCT). We also checked conference proceedings for relevant abstracts, and contacted researchers, organizations, and pharmaceutical companies. Randomized controlled trials of antibiotics for Shigella dysentery. Four authors, working in pairs, independently assessed trial eligibility, methodological quality, and extracted data. We calculated risk ratios (RR) with 95% confidence intervals (CI) for dichotomous data, and used the random-effects model for significant heterogeneity. We explored possible sources of heterogeneity, when present, in subgroup analyses of participant age and percentage of participants with confirmed Shigella infection. Sixteen trials (1748 participants), spanning four decades and with differing sensitivity to Shigella isolates, met the inclusion criteria. Seven were judged to be at risk of bias due to inadequate allocation concealment or blinding, and 12 due to incomplete reporting of outcome data. Limited data from one three-armed trial of people with moderately severe illness suggest that antibiotics reduce the episodes of diarrhoea at follow-up (furazolidone versus no drug RR 0.21, 95% CI 0.09 to 0.48, 73 participants; cotrimoxazole versus no drug RR 0.30, 95% CI 0.15 to 0.59, 76 participants).There was insufficient evidence to consider any class of antibiotic superior in efficacy in treating Shigella dysentery, but heterogeneity for some comparisons limits confidence in the results. All the antibiotics studied were safe. There was inadequate evidence regarding the role of antibiotics in preventing relapses. Antibiotics reduce the duration of Shigella dysentery.Regularly updated local or regional antibiotic sensitivity patterns to different species and strains of Shigella are required to guide empiric therapy. More trials adhering to standard guidelines are required to evaluate the role of antibiotics in the treatment of severe forms of Shigella dysentery and in groups who are at high risk of complications.This publication has 103 references indexed in Scilit:
- A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and MicrobiologyPLoS Medicine, 2006
- A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosisThe Journal of Pediatrics, 1993
- Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in childrenThe Journal of Pediatrics, 1991
- Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosisThe Journal of Pediatrics, 1988
- Treatment of Travelers' Diarrhea with Trimethoprim/Sulfamethoxazole and with Trimethoprim AloneThe New England Journal of Medicine, 1982
- Comparison of trimethoprim-sulfamethoxazole and ampicillin therapy for shigellosis in ambulatory patientsThe Journal of Pediatrics, 1976
- Optimal dosage of ampicillin for shigellosisThe Journal of Pediatrics, 1969
- Comparison of intramuscular and oral ampicillin therapy for shigellosisThe Journal of Pediatrics, 1968
- Comparison of orally absorbable andnonabsorbable antibiotics in shigellosis: A double-blind study with ampicillin and neomycinThe Journal of Pediatrics, 1968
- Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placeboThe Journal of Pediatrics, 1967